Flumazenil attenuates the pituitary response to CRH in healthy males
- 30 November 1996
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 6 (4) , 323-325
- https://doi.org/10.1016/s0924-977x(96)00040-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamusNeuroscience, 1994
- Flumazenil has an anxiolytic effect in simulated stressPsychopharmacology, 1994
- Benzodiazepine-induced sedation and cortisol suppressionPsychopharmacology, 1992
- Effects of chlordiazepoxide, flumazenil and DMCM on plasma catecholamine and corticosterone concentrations in ratsPharmacology Biochemistry and Behavior, 1991
- Flumazenil Provocation of Panic AttacksArchives of General Psychiatry, 1990
- In Vitroandin VivoEffects of the Triazolobenzodiazepine Alprazolam on Hypothalamic Pituitary-Adrenal Function: Pharmacological and Clinical Implications*Journal of Clinical Endocrinology & Metabolism, 1990
- Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict testPsychopharmacology, 1988
- Factors modifying the effect of diazepam on plasma corticosterone levels in ratsLife Sciences, 1988
- RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.British Journal of Clinical Pharmacology, 1982
- Selective antagonists of benzodiazepinesNature, 1981